Haemophilia management in New Zealand: an Auckland perspective.
作者信息
Ockelford P A, Benny A G, Van de Water N S, Berry E W
机构信息
Protein Chemistry Laboratory, Blood Transfusion Centre, Auckland.
出版信息
N Z Med J. 1989 Apr 26;102(866):189-91.
PMID:2496366
Abstract
摘要
相似文献
1
Haemophilia management in New Zealand: an Auckland perspective.
N Z Med J. 1989 Apr 26;102(866):189-91.
2
DNA diagnosis in haemophilia management: who will pay to save?血友病治疗中的DNA诊断：谁来为拯救买单？
N Z Med J. 1989 Feb 8;102(861):55.
3
Molecular genetics and counselling in haemophilia.血友病的分子遗传学与遗传咨询
Thromb Haemost. 1995 Jul;74(1):40-4.
4
Treatment of hemophilia.血友病的治疗。
Schweiz Med Wochenschr Suppl. 1991;43:82-9.
5
Progress and problems in hemophilia and von Willebrand's disease.血友病和血管性血友病的进展与问题
Adv Pediatr. 1984;31:137-77.
6
[Carrier detection and prenatal diagnosis for hemophilia A using the inversion analysis of the factor VIII gene].[利用凝血因子VIII基因倒位分析进行甲型血友病的携带者检测和产前诊断]
Rinsho Ketsueki. 1995 Nov;36(11):1252-6.
7
Haemophilia--darkest hours before the dawn.血友病——黎明前最黑暗的时刻。
Med J Aust. 1996 Apr 15;164(8):453-5.
8
Haemophilia: strategies for carrier detection and prenatal diagnosis.血友病：携带者检测与产前诊断策略
Bull World Health Organ. 1993;71(3-4):429-58.
9
[Hemophilia, carrier state and prenatal diagnosis].[血友病、携带者状态与产前诊断]
Ned Tijdschr Geneeskd. 1984 Feb 25;128(8):360-2.
10
Impact of factor VIII deficiency on clotting factor utilization in the United States.美国血友病A患者凝血因子使用情况及影响因素分析
Ric Clin Lab. 1983 Jan-Mar;13(1):33-41. doi: 10.1007/BF02904743.
引用本文的文献
1
Restriction fragment length polymorphisms associated with the factor VIII and factor IX genes in Polynesians.
J Med Genet. 1991 Mar;28(3):171-6. doi: 10.1136/jmg.28.3.171.
Zotero 插件